Jump Financial LLC Boosts Stock Position in CME Group Inc. $CME

Key Points

• Jump Financial LLC increased its position in CME Group Inc. by 22.2% during the first quarter, owning 127,627 shares valued at approximately $33.86 million.
• A significant number of large investors also raised their holdings in CME Group, with some, like SVB Wealth LLC, increasing their stakes by over 111%.
• CME Group announced a quarterly dividend of $1.25 per share, with an expected annualized yield of 1.9%, payable on September 25th to shareholders of record by September 9th.

Jump Financial LLC boosted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 22.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 127,627 shares of the financial services provider's stock after purchasing an additional 23,168 shares during the period. CME Group comprises approximately 0.5% of Jump Financial LLC's portfolio, making the stock its 17th biggest holding. Jump Financial LLC's holdings in CME Group were worth $33,858,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of CME. GQG Partners LLC lifted its stake in CME Group by 7,676.3% in the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock valued at $584,975,000 after purchasing an additional 2,176,685 shares during the last quarter. Wellington Management Group LLP lifted its stake in CME Group by 370.5% in the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock valued at $704,068,000 after purchasing an additional 2,089,935 shares during the last quarter. GAMMA Investing LLC lifted its stake in CME Group by 32,941.0% in the first quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock valued at $493,144,000 after purchasing an additional 1,853,261 shares during the last quarter. Nuveen LLC purchased a new position in CME Group in the first quarter valued at approximately $218,842,000. Finally, Egerton Capital UK LLP lifted its stake in CME Group by 79.4% in the first quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider's stock valued at $459,003,000 after purchasing an additional 765,773 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Price Performance

NASDAQ:CME traded down $1.49 during midday trading on Wednesday, hitting $270.12. The company had a trading volume of 1,397,231 shares, compared to its average volume of 2,322,690. The stock's fifty day moving average price is $275.93 and its 200-day moving average price is $268.87. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52-week low of $207.75 and a 52-week high of $290.79. The company has a market capitalization of $97.35 billion, a PE ratio of 26.15, a P/E/G ratio of 4.91 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the business posted $2.56 earnings per share. The company's revenue was up 10.4% on a year-over-year basis. As a group, research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio is presently 48.40%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on CME shares. Piper Sandler upped their price objective on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Citigroup upped their price target on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Barclays set a $298.00 target price on shares of CME Group and gave the stock an "equal weight" rating in a research report on Thursday, July 24th. Finally, UBS Group reiterated a "neutral" rating and issued a $305.00 target price on shares of CME Group in a research report on Thursday, July 24th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $261.93.

Insider Buying and Selling at CME Group

In other CME Group news, Director Charles P. Carey sold 500 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the sale, the director directly owned 4,900 shares in the company, valued at $1,300,215. This represents a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director William R. Shepard purchased 256 shares of the business's stock in a transaction on Wednesday, June 25th. The shares were acquired at an average price of $270.53 per share, with a total value of $69,255.68. Following the completion of the transaction, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.30% of the company's stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.